Needham & Company Upgrades Multi-Fineline (MFLX) to Buy; Buy on Weakness
Get Alerts MFLX Hot Sheet
Price: $17.02 -0.12%
Rating Summary:
0 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
0 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Needham & Company upgraded Multi-Fineline (NASDAQ: MFLX) from Neutral to Buy with a price target of $27.00.
Analyst, Richard Kugele, said, "Messy F2Q? Yes. Weak F3Q guide? Again, yes. Broken story? Far from it, in our view. Stock likely lower at open? Probably, and we see the opportunity we have been waiting for. Consequently, we are upgrading MFLX, a company at the center of the smartphone and tablet adoption wave, to Buy."
Kugele lowers FY12 EPS estimate from $1.77 to $1.44, but raises FY13 from $1.88 to $2.70.
For an analyst ratings summary and ratings history on Multi-Fineline click here. For more ratings news on Multi-Fineline click here.
Shares of Multi-Fineline closed at $25.02 yesterday.
Analyst, Richard Kugele, said, "Messy F2Q? Yes. Weak F3Q guide? Again, yes. Broken story? Far from it, in our view. Stock likely lower at open? Probably, and we see the opportunity we have been waiting for. Consequently, we are upgrading MFLX, a company at the center of the smartphone and tablet adoption wave, to Buy."
Kugele lowers FY12 EPS estimate from $1.77 to $1.44, but raises FY13 from $1.88 to $2.70.
For an analyst ratings summary and ratings history on Multi-Fineline click here. For more ratings news on Multi-Fineline click here.
Shares of Multi-Fineline closed at $25.02 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Coherent (COHR) PT Raised to $420 at Needham
- Globant S.A. (GLOB) PT Lowered to $45 at Needham
- Canaccord Upgrades HLS Therapeutics (HLS:CN) (HLTRF) to Buy
Create E-mail Alert Related Categories
Analyst EPS Change, Analyst EPS View, UpgradesRelated Entities
Needham & CompanySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share